the response was tumor-specific and histologic type-specific since 16 out of 52 ( 30 % ) melanoma patient sera taken before surgery reacted against melanoma cells , whereas 3 out of 43 ( 7 % ) control sera , collected from patients with unrelated tumors and from cancer-free individuals , were positive .
C0025202
patient
C1513095
melanoma cells